Global Inhaled and Intranasal Products Contract Service Providers Market Size study & Forecast, by Product by Services and Regional Analysis, 2022-2029

  • Publish Date: Feb,2023
  • Report ID: 3-2-1643
  • Page : 200
  • Report Type : PDF (Email)
Global Inhaled and Intranasal Products Contract Service Providers Market is valued at approximately USD 2.21 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 8.5% over the forecast period 2022-2029. Inhaled and intranasal products is a specially designed medical device that is used for the prevention of asthma and the management of allergy, hayfever, and some nasal conditions. The contract service providers are contract regulates relations in the rendering of professional services between a party which offers the specified service and another the recipient thereof in exchange for a payment. The growing awareness of the effective and advanced respiratory devices, increase in geriatric population, and ease of regulatory compliance are the primary factors that are attributing towards the market demand across the globe.

The increasing incidences of chronic respiratory diseases is acting as a catalyzing factor for the growth of the market. The World Health Organization (WHO) reported that the respiratory disease infections as the third leading cause of mortality, which is accounting for around 3 million deaths year (or 6% of all fatalities worldwide), with nearly 90% of COPD fatalities occurring in individuals over 70 from low- and middle-income nations. Also, there are around 262 million patients were estimated to suffer from asthma, which commonly affects children. Thus, theses aforementioned factors are directly associated growth of the inhaled and intranasal products contract service providers. Moreover, rising investment in the development of advanced technology, as well as the rising launch of the latest technology-based nebulizers are presenting various lucrative opportunities over the forecasting years. However, stringent government regulations for the product approval are a restricting the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Inhaled and Intranasal Products Contract Service Providers Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. The Asia Pacific dominated the market in terms of revenue, owing to the increasing incidences of respiratory disorder, along with the rising government initiatives and implementation of several policies. Whereas, North America is expected to grow with the highest CAGR during the forecast period, owing to factors such as the favorable reimbursement scenario, as well as presence of a large number of contract manufacturers in the market space.

Major market players included in this report are:


Catalent Inc.

Kindeva Drug Delivery


Quotient Services



Beximo Pharmaceuticals

DPT Laboratories


Recent Developments in the Market:

In March 2022, Lonza unveiled the company's membership in the International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS) of inhalation products. The initiative is likely to support the inhalation-related businesses of Lonza will benefit significantly from this participation, such as the opportunity to participate in team research projects, use market benchmarking, gather, and evaluate data, and communicate with regulators.
Global Inhaled and Intranasal Products Contract Service Providers Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Product, Services, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Metered - dose Inhalers

Dry Powder Inhalers



By Services:

Quality Assurance

Regulatory Affair Services

Product Design & Development

Product Maintenance

Contract Manufacturing


By Region:

North America










Asia Pacific





South Korea


Latin America




Rest of the World